Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bondronat Loading Dose in Lung Cancer Bone Metastasis
NCT00492843Phase 4Terminated
- Sponsor
- Chinese Society of Lung Cancer
- Start
- Jul 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ibandronic acid in skeletal metastasis, sponsored by Chinese Society of Lung Cancer. Started Jul 2007; status: terminated.
02
Drugs
ibandronic acid
03
Conditions
skeletal metastasis
Beyond the preview
Go deeper on NCT00492843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492843.